PDF(912 KB)
Cost-effectiveness analysis of selumetinib in the treatment of symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in Chinese children aged 3–18 years
ZHOU Wanxin, YANG Mengyu, CHANG Feng, LU Yun, ZHU Yumei
Chinese Journal of Hospital Pharmacy ›› 2025, Vol. 45 ›› Issue (2) : 181-187.
PDF(912 KB)
PDF(912 KB)
Cost-effectiveness analysis of selumetinib in the treatment of symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in Chinese children aged 3–18 years
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
